1. Scrip
  2. >>Business

GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy

 
• By Sukaina Virji

GSK’s new CEO will be Emma Walmsley, currently head of its Consumer Healthcare division. While some investors had wished for a company outsider with a ‘fresh pair of eyes’, GSK’s board decided to go for the best of both worlds: an insider with plenty of non-pharma experience.

Emma Walmsley GSK
CEO Designate Emma Walmsley • Source: GSK

Emma Walmsley will succeed Andrew Witty as GSK CEO when he retires on March 31st 2017. Prior to her current role as CEO of GSK’s Consumer Healthcare division, she was president of GSK Consumer Healthcare and has been a member of GSK’s corporate executive team since 2011.

Walmsley joined GSK in 2010 from L’Oréal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the UK, Europe and USA

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Merck’s Welireg Adrenal Tumor Rollout Targets Specialized Centers

 
• By Alaric DeArment

The drugmaker won US FDA approval for the HIF-2α inhibitor in pheochromocytoma and paraganglioma, a rare cancer of the adrenal glands, in adolescents and adults.

Most Favored Nation Policy ‘Lazy, Misguided,’ But US Price Reforms Politically ‘Inevitable’

 
• By Cathy Kelly

Policy experts and pharma executives react to President Trump’s executive order on “equalizing” drug prices between the US and comparable nations at the ISPOR 2025 conference.

Merck KGaA Braces For Volatility But Does Not Expect Europe To Budge On Pricing

 
• By Andrew McConaghie

Shares are hit as German conglomerate lowers revenue forecast.